Dear Sir/Madam,

We invite you to participate in a multicenter observational study titled "Evaluation of therapeutic effect of lanadelumab used in Polish patients with hereditary angioedema within the Drug Program", with the primary objectives of determining the effectiveness of lanadelumab in patients with hereditary angioedema type I and II and describing the clinical and demographic characteristics of the population treated within the Drug Program.

To start the study, an online agreement is required, so please register and follow the instructions appearing on the computer screen.

After successful registration and signing the agreement electronically, please log in with the data obtained during the account setup.